Skip to content

Effects of Forgiveness-Based Group Psychoeducation Applied to Cancer Survivors

Effects of Forgiveness-Based Group Psychoeducation Applied to Cancer Survivors on Fear of Cancer Recurrence, Forgiveness and Psychiatric Symptoms: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06867640
Enrollment
64
Registered
2025-03-10
Start date
2025-04-02
Completion date
2025-07-14
Last updated
2025-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Survivors

Keywords

Cancer Survivors, Forgiveness, Psychoeducation, Fear of Cancer Recurrence, Quality of Life, Psychiatric Symptoms

Brief summary

This study aims to examine the effects of forgiveness-based group psychoeducation applied to cancer survivors on fear of cancer recurrence, forgiveness and psychiatric symptoms.

Detailed description

This study was designed as a randomized controlled experimental study with a pre-test-post-test and follow-up design to examine the effects of forgiveness-based group psychoeducation on fear of cancer recurrence, forgiveness and psychiatric symptoms of cancer survivors. The aim is to evaluate the effects of a forgiveness-based psychoeducation program on cancer survivors. After the Informed Voluntary Consent Form is obtained from individuals who agree to participate in the study, the Introductory Information Form, Heartland Forgiveness Scale, Fear of Relapse Inventory and Brief Symptom Inventory will be applied. Pre-tests will be applied to the sample determined by an independent statistician. Then, participants will be divided into intervention and control groups by simple randomization method. Face-to-face forgiveness-based psychoeducation will be applied to the intervention group in 90-minute sessions once/twice a week, totaling 6 sessions. In the last session of psychoeducation, a post-test (Introductory Information Form, Heartland Forgiveness Scale, Fear of Relapse Inventory and Brief Symptom Inventory) will be administered to both the intervention and control groups. The first follow-up test of the study will be administered to both the intervention and control groups 1 month after the post-test, and the second follow-up test of the study will be administered 3 months after the post-test. After the completion of the study and the measurements, it is planned to provide forgiveness-based psychoeducation to the participants in the control group.

Interventions

OTHERForgiveness-Based Group Psychoeducation

The effect of forgiveness-based group psychoeducation applied to cancer survivors on fear of cancer recurrence, forgiveness and psychiatric conditions.

Sponsors

Saglik Bilimleri Universitesi
CollaboratorOTHER
Hilal Merve Belen
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

The process of assigning participants to groups will be carried out by a statistician outside the study using the simple randomization method and will be hidden from the researcher until the application begins. Since the assignment to groups will be made after informed consent is obtained, the participants will be blinded (single blind). In addition, the statistician will also be blinded in order to reduce statistical analysis and reporting bias. Without specifying which group (intervention and control group) the data belong to, they will be coded and transferred to the database (group A, group B), and the data will be analyzed and reported.

Intervention model description

Forgiveness-Based Group Psychoeducation

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Written and verbal consent to participate in the study * Understanding and speaking Turkish * Being over 18 years old * Not having any visual, hearing or mental disabilities * Having been diagnosed with cancer, treated with curative intent and having completed major treatments (surgery, radiotherapy, chemotherapy) within the last 5 years

Exclusion criteria

* Not volunteering to participate in research * Having a visual, hearing or mental disability * Agreeing to participate in another psychoeducational program conducted simultaneously with the research * Inability to communicate in Turkish * Having previously received training in forgiveness and/or coping with fear of relapse

Design outcomes

Primary

MeasureTime frameDescription
Heartland Forgiveness ScaleBaseline, 6 th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)The scale, which evaluates the level of forgiveness and consists of 18 items, consists of three sub-dimensions: forgiveness of self, forgiveness of others and forgiveness of the situation. The items of the Likert-type scale are evaluated according to a 7-point evaluation scale and the evaluation is answered as does not reflect me at all (1 point), does not reflect me very much (3 points), reflects me a little (5 points) and reflects me completely (7 points). Items 2, 4, 6, 7, 9, 11, 13, 15 and 17 in the scale items are scored reversely. The scale is evaluated according to total and sub-scale scores and there is no cut-off score. High scores obtained from each of the sub-dimensions of the scale indicate a high or low level of forgiveness in the relevant sub-dimension. The total forgiveness score is formed by summing the scores of the sub-dimensions of the scale.

Secondary

MeasureTime frameDescription
Brief Symptom InventoryBaseline, 6th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)It is a Likert-type scale and the items are scored by rating them between 0 and 4, with the statements not at all and a lot. People who will fill out the scale are asked to read each item separately and indicate how much each of these symptoms has bothered them in the last week, including that day. When the total for each subscale is divided by the number of items in that subscale, a score for that dimension is obtained. Brief Symptom Inventory subscale dimensions and items; anxiety; items 12, 13, 28, 31, 32, 36, 38, 42, 43, 45, 46, 47, 49; depression; items 9, 14, 16, 17, 18, 19, 20, 25, 27, 35, 37, 39; negative self; Items 15, 21, 22, 24, 26, 34, 44, 48, 50, 51, 52, 53; somatization; items 2, 5, 7, 8, 11, 23, 29, 30, 33; hostality; items 1, 3, 4, 6, 10, 40, 41.
Fear of Cancer Recurrence InventoryBaseline, 6th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)The scale, which has a five-point Likert structure, consists of 42 items and 7 sub-dimensions. These sub-dimensions are; triggers (items 1-8 and 9-17), psychological distress (items 18-21), functional disorders (items 22-27), insight (items 28-30), self-relaxation methods (items 31-33), coping methods (items 34-42). The scale, which does not have any cut-off point, is scored as 0-4 points. It is obtained by adding the questions in each sub-dimension straight, except for question 43. The total scores that can be obtained from the scale are between 0-168, and as the score increases, it is judged that the fear of relapse increases.

Other

MeasureTime frameDescription
Introductory Information FormBaseline, 1st month follow-up, 3rd month follow-up (Pre-test-post-test follow-up experimental design)It was created by the researchers in line with the literature information in order to determine the participants' sociodemographic (age, gender, marital status, education level, etc.) and diagnosis-treatment process-related characteristics.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026